ATE520401T1 - Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon - Google Patents

Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon

Info

Publication number
ATE520401T1
ATE520401T1 AT08702047T AT08702047T ATE520401T1 AT E520401 T1 ATE520401 T1 AT E520401T1 AT 08702047 T AT08702047 T AT 08702047T AT 08702047 T AT08702047 T AT 08702047T AT E520401 T1 ATE520401 T1 AT E520401T1
Authority
AT
Austria
Prior art keywords
benzothiazolone
beta
combinations
adrenoceptor agonist
adrenoceptor
Prior art date
Application number
AT08702047T
Other languages
English (en)
Inventor
Elaine Bridget Cadogan
Stephen Connolly
David Nicholls
Katherine Wiley
Alan Young
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE520401T1 publication Critical patent/ATE520401T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08702047T 2007-02-08 2008-02-06 Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon ATE520401T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0702456.5A GB0702456D0 (en) 2007-02-08 2007-02-08 New combination
PCT/GB2008/000386 WO2008096111A1 (en) 2007-02-08 2008-02-06 Combinations of beta- 2 -adrenoceptor agonistic benzothiazolone

Publications (1)

Publication Number Publication Date
ATE520401T1 true ATE520401T1 (de) 2011-09-15

Family

ID=37898976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08702047T ATE520401T1 (de) 2007-02-08 2008-02-06 Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon

Country Status (29)

Country Link
US (2) US20100029732A1 (de)
EP (2) EP2364704A1 (de)
JP (1) JP2010518056A (de)
KR (1) KR20090114391A (de)
CN (1) CN101652137A (de)
AR (1) AR065277A1 (de)
AT (1) ATE520401T1 (de)
AU (1) AU2008212713A1 (de)
BR (1) BRPI0806964A2 (de)
CA (1) CA2675465A1 (de)
CL (1) CL2008000379A1 (de)
CO (1) CO6210723A2 (de)
CY (1) CY1111932T1 (de)
DK (1) DK2117542T3 (de)
EC (1) ECSP099567A (de)
ES (1) ES2368967T3 (de)
GB (1) GB0702456D0 (de)
HR (1) HRP20110695T1 (de)
IL (1) IL199840A0 (de)
MX (1) MX2009007865A (de)
PE (1) PE20081759A1 (de)
PL (1) PL2117542T3 (de)
PT (1) PT2117542E (de)
RS (1) RS51956B (de)
RU (1) RU2009133255A (de)
SI (1) SI2117542T1 (de)
TW (1) TW200843750A (de)
UY (1) UY30906A1 (de)
WO (1) WO2008096111A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
NZ589091A (en) 2008-05-13 2011-07-29 Astrazeneca Ab Quinuclidine derivatives as muscarinic m3 receptor antagonists
CN102908624A (zh) * 2008-05-13 2013-02-06 阿斯利康(瑞典)有限公司 包含毒蕈碱性受体拮抗剂和β2-肾上腺素受体激动剂的药物产品
WO2009154557A1 (en) 2008-06-18 2009-12-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
CN102131505A (zh) * 2008-06-20 2011-07-20 阿斯利康(瑞典)有限公司 用于调节β2-肾上腺素受体活性的包含4-羟基-2-氧代-2,3-二氢-1,3-苯并噻唑-7-基化合物的药物组合物
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
US9827212B2 (en) 2009-03-18 2017-11-28 The Trustees Of The University Of Pennsylvania Compositions and methods for treating asthma and other lung diseases
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
EP3061821B1 (de) 2009-07-22 2019-07-10 Puretech Health LLC Zusammensetzungen zur behandlung von durch muscarinrezeptoraktivierung gelinderten leiden
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
SG11201700536XA (en) 2014-09-09 2017-02-27 Vectura Ltd Formulation comprising glycopyrrolate, method and apparatus
ES2760466T3 (es) * 2015-05-04 2020-05-14 Astrazeneca Ab Derivados de pirazol útiles como inhibidores de la proteína activadora de 5-lipoxigenasa (FLAP)
IL281809B (en) 2018-09-28 2022-09-01 Karuna Therapeutics Inc Compositions and methods for the treatment of diseases improved by the activation of muscarinic receptors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (de) 1972-05-19 1975-08-18 Bofors Ab
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0104251D0 (sv) 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
GB0324790D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
GB0402797D0 (en) * 2004-02-09 2004-03-10 Novartis Ag Organic compounds
SE0401762D0 (sv) 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
EP1786813A2 (de) 2004-09-03 2007-05-23 Plexxikon, Inc. Bizyklische heteroaryl-pde4b-inhibitoren
CA2584413A1 (en) 2004-10-29 2006-05-04 Astrazeneca Ab Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
US20090012051A1 (en) 2005-03-15 2009-01-08 Kyowa Hakko Kogyo Co., Ltd. External preparation
TW200738658A (en) * 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200821316A (en) 2006-07-19 2008-05-16 Astrazeneca Ab Novel compounds 243

Also Published As

Publication number Publication date
EP2364704A1 (de) 2011-09-14
EP2117542A1 (de) 2009-11-18
JP2010518056A (ja) 2010-05-27
US20080242649A1 (en) 2008-10-02
IL199840A0 (en) 2010-04-15
US20100029732A1 (en) 2010-02-04
DK2117542T3 (da) 2011-10-31
RU2009133255A (ru) 2011-03-20
CL2008000379A1 (es) 2008-10-24
AU2008212713A1 (en) 2008-08-14
BRPI0806964A2 (pt) 2014-04-08
KR20090114391A (ko) 2009-11-03
MX2009007865A (es) 2009-07-31
PT2117542E (pt) 2011-10-06
CN101652137A (zh) 2010-02-17
AR065277A1 (es) 2009-05-27
CO6210723A2 (es) 2010-10-20
CY1111932T1 (el) 2015-11-04
GB0702456D0 (en) 2007-03-21
RS51956B (sr) 2012-02-29
SI2117542T1 (sl) 2011-11-30
WO2008096111A1 (en) 2008-08-14
PL2117542T3 (pl) 2011-12-30
PE20081759A1 (es) 2009-01-31
ES2368967T3 (es) 2011-11-24
EP2117542B1 (de) 2011-08-17
CA2675465A1 (en) 2008-08-14
UY30906A1 (es) 2008-09-30
HRP20110695T1 (hr) 2011-11-30
TW200843750A (en) 2008-11-16
ECSP099567A (es) 2009-09-29

Similar Documents

Publication Publication Date Title
BRPI0818301A2 (pt) Composições e métodos para intensificar a função cognitiva
AT503053A3 (de) Kombination aus einem träger und einem wafer
DK2117542T3 (da) Kombinationer af beta-2-adrenoceptor-agonistisk benzothiazolon
BRPI0909776A2 (pt) bujão perfurável co-moldado e método para fabricação do mesmo
DE112008002974B8 (de) Masseanschlussfahne und Erdungsvorrichtung hiermit
EP2188630A4 (de) Methoden und kompositionen in bezug auf synergistische antworten auf onkogene mutationen
EP2632893A4 (de) Esteramine und derivate aus erdölmetathesen
BRPI1007541A2 (pt) dispositivo de perfuração de alargamento de furo e métodos para usar o mesmo
EP2376422A4 (de) Nebenproduktstromderivate aus einem cyclohexanoxidationsverfahren und verwendungsverfahren dafür
EP2257592A4 (de) Reduktion von aldehyden in aminen
DK2185552T3 (da) Dipeptoid-prodrugs og anvendelse heraf
BRPI0814758A2 (pt) Piridinacarboxamida e derivados de benzamida como ligantes taar1
DE602009000812D1 (de) Ölabscheidevorrichtung und Turbotriebwerk umfassend diese Vorrichtung
PL3335707T3 (pl) Kombinacje antagonisty receptora muskarynowego i agonisty receptora beta-2 adrenergicznego
UY3820Q (es) Epiladora con recortadora de 21mm
IL232477A (en) Cyclohexylamine derivatives with the activity of beta 2-adrenergic agonist and 3m muscarinic antagonist
PL2315782T3 (pl) Nowy materiał polidekstrozowy
DE602008000291D1 (de) Steckverbinder und Montageverfahren dafür
DE602006016101D1 (de) Resttonerfördervorrichtung bestehend aus einem gewickelten Kunststoffteil
DE502008002642D1 (de) Überspannungsableiter
EP2261637A4 (de) Widerstandsprüfverfahren und vorrichtung dafür
EP2464350A4 (de) Zusammensetzungen und verfahren zur intensivierung kognitiver und verwandter funktionen bei tieren
DE602008004799D1 (de) Steckverbinder und Montageverfahren dafür
EP2238075A4 (de) Nanodiamanten und diamantenähnliche partikel aus kohlenstoffhaltigem material
BRPI0821367A2 (pt) Pneumático e utilização do mesmo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2117542

Country of ref document: EP